NEW YORK--(BUSINESS WIRE)--Nov. 7, 2005--Data from the Columbia University Department of Urology demonstrates that Zyflamend(R), a unique herbal extract preparation, suppresses the growth of prostate cancer cells and induces prostate cancer cells to self-destruct via a process called “apoptosis.”
